Marinkovich MP, Herron GS, Kavari PA, Bauer EA.Hereditary epidermolysis bullosa.In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:690-702.
Stanley JR.Pemphigus.In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:654-666.
Anhalt G, Kim S, Stanley J.
et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated
with neoplasia. N Engl J Med.1990;323:1729-1735.
Anhalt GJ.Paraneoplastic pemphigus. Adv Dermatol.1997;12:77-96.
Amagai M, Karpati S, Prussick R, Klaus-Kovtun V, Stanley J.Autoantibodies against the amino-terminal cadherin-like domain of pemphigus
vulgaris are pathogenic. J Clin Invest.1992;90:919-926.
Lin MS, Mascaro JM, Liu Z, Espana A, Diaz LA.The desmosome and hemidesmosome in cutaneous autoimmunity. Clin Exp Immunol.1997;107(suppl 1):9S-15S.
Sams WMJ, Jordan RE.Correlation of pemphigoid and pemphigus antibody titres with activity
of disease. Br J Dermatol.1971;84:7-13.
Ishii K, Amagai M, Hall RP.
et al. Characterization of autoantibodies in pemphigus using antigen-specific
enzyme-linked immunosorbent assays with baculovirus-expressed recombinant
proteins. J Immunol.1997;159:2010-2017.
Chowdhury MMU, Natarajan S.Neonatal pemphigus associated with mild oral pemphigus vulgaris in
the mother during pregnancy. Br J Dermatol.1998;139:500-503.
Schlitz JR, Micheal B.Production of epidermal acantholysis in normal human skin in vitro
by the IgG fraction from pemphigus serum. J Invest Dermatol.1976;67:254-260.
Hashimoto K, Shafran KM, Webber PS, Lazaraus GS, Singer KH.Anti-cell surface pemphigus autoantibody stimulates plasminogen activator
activity of human epidermal cells. J Exp Med.1983;157:259-272.
Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA.Induction of pemphigus in neonatal mice by passive transfer of IgG
from patients with the disease. N Engl J Med.1982;306:1189-1196.
Roscoe JT, Diaz L, Sampaio SA.
et al. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c
mice by passive transfer. J Invest Dermatol.1985;85:538-541.
Amagai M.Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol.1996;11:319-352.
Kowalcyk AP, Bornslaeger EA, Norvell SM, Palka HL, Green KJ.Desmosomes: intracellular adhesive junctions specialized for attachment
of intermediate filaments. Int Rev Cytol.1999;185:237-302.
Ding X, Aoki V, Mascaro JM, Lopez-Swiderski A, Diaz LA, Fairley JA.Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct
antibody profiles. J Invest Dermatol.1997;109:592-596.
Amagai M, Nishikawa T, Nousari H.Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present
in sera from patients with paraneoplastic pemphigus and cause acantholysis
in vivo in neonatal mice. J Clin Invest.1998;102:775-782.
Mahoney MG, Aho S, Uitto JR, Stanley JR.The members of the plakin family of proteins recognized by paraneoplastic
pemphigus antibodies include periplakin. J Invest Dermatol.1998;111:308-313.
Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T.Antigen-specific immunoabsorption of pathogenic autoantibodies in pemphigus
foliaceus. J Invest Dermatol.1995;104:895-901.
Amagai M, Hashimoto T, Green KJ, Shimizu N, Nishikawa T.Absorption of pathogenic antibodies by the extracellular domain of
pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest.1994;94:59-67.
Koch PJ, Mahoney MG, Ishikawa H.
et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3)
gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar
to pemphigus vulgaris. J Cell Biol.1997;137:1091-1102.
Mahoney MG, Wang Z, Rothenberger K.
et al. Explanations for the clinical and microscopic localization of lesions
of pemphigus foliaceus and pemphigus vulgaris. J Clin Invest.1999;103:461-468.
Wucherpfennig KW, Yu B, Bhol K.
et al. Structural basis for major histocompatibilty complex (MHC)–linked
susceptibility to autoimmunity: charged residues of a single MHC binding pocket
confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A.1995;92:11935-11939.
Lin MS, Swartz SJ, Lopez A.
et al. Development and characterization of desmoglein-3 specific T cells from
patients with pemphigus vulgaris. J Clin Invest.1997;99:31-40.
Cohen PL.Systemic autoimmunity.In: Paul WE, ed. Fundamental Immunology.
Philadelphia, Pa: Lippincott-Raven; 1999:1067-1088.
Shevach EM.Organ-specific autoimmunity.In: Paul WE, ed. Fundamental Immunology.
Philadelphia, Pa: Lippincott-Raven; 1999:1089-1125.
Sampaio SA, Rivitti EA, Aoki V, Daiz LA.Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo
selvagem (wild fire). Dermatol Clin.1994;12:765-776.
Moraes ME, Fernandez-Vina M, Lazaro A.
et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus
(fogo selvagem) in three different Brazilian populations. Tissue Antigens.1997;49:35-40.
Eaton DP, Diaz LA, Hans-Filho G.
et al. for The Cooperative Group on Fogo Selvagem Research. Comparison of black fly species (Diptera: Simuliidae) on an Amerindian
reservation with a high prevalence of fogo selvagem to neighboring disease-free
sites in the state of Mato Grosso do Sol, Brazil. J Med Entomol.1998;35:120-131.
Huilgol SC, Black MM.Management of the immunobullous disorders, II: pemphigus. Clin Exp Dermatol.1995;20:283-293.
Bystryn JC, Steinman NM.The adjuvant therapy of pemphigus. Arch Dermatol.1996;132:203-212.
Stanley JR.Therapy of pemphigus vulgaris. Arch Dermatol.1999;135:76-78.
Enk AH, Knop J.Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol.1999;135:54-56.